Similar articles

• CSF1R Blockade for Refractory Chronic Graft-versus-Host Disease.

  Mohty M. Mohty M. N Engl J Med. 2024 Sep 19;391(11):1055-1059. doi: 10.1056/NEJMe2407369. N Engl J Med. 2024. PMID: 39292933 No abstract available.
• Axatilimab in Recurrent or Refractory Chronic Graft-versus-Host Disease.

  Wolff D, Cutler C, Lee SJ, Pusic I, Bittencourt H, White J, Hamadani M, Arai S, Salhotra A, Perez-Simon JA, Alousi A, Choe H, Kwon M, Bermúdez A, Kim I, Socié G, Chhabra S, Radojcic V, O'Toole T, Tian C, Ordentlich P, DeFilipp Z, Kitko CL; AGAVE-201 Investigators. Wolff D, et al. N Engl J Med. 2024 Sep 19;391(11):1002-1014. doi: 10.1056/NEJMoa2401537. N Engl J Med. 2024. PMID: 39292927 Clinical Trial.
• Acute graft-vs-host disease: pathobiology and management.

  Goker H, Haznedaroglu IC, Chao NJ. Goker H, et al. Exp Hematol. 2001 Mar;29(3):259-77. doi: 10.1016/s0301-472x(00)00677-9. Exp Hematol. 2001. PMID: 11274753 Review.
• CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation.

  Locke FL, Pidala J, Storer B, Martin PJ, Pulsipher MA, Chauncey TR, Jacobsen N, Kröger N, Walker I, Light S, Shaw BE, Beato F, Laport GG, Nademanee A, Keating A, Socie G, Anasetti C. Locke FL, et al. Biol Blood Marrow Transplant. 2017 Mar;23(3):405-411. doi: 10.1016/j.bbmt.2016.12.624. Epub 2016 Dec 19. Biol Blood Marrow Transplant. 2017. PMID: 28007665 Free PMC article. Clinical Trial.
• Translational Clinical Strategies for the Prevention of Gastrointestinal Tract Graft Versus Host Disease.

  Rayasam A, Drobyski WR. Rayasam A, et al. Front Immunol. 2021 Nov 26;12:779076. doi: 10.3389/fimmu.2021.779076. eCollection 2021. Front Immunol. 2021. PMID: 34899738 Free PMC article. Review.